RxFunction

Executive Summary

RxFunction is a medical device company pioneering wearable sensory prostheses to address balance and mobility impairments in patients with peripheral neuropathy. Its flagship product, Walkasins, is a prescription device that replaces lost foot pressure sensation, improving gait control and reducing fall risk. Founded in 2015 and headquartered in Eden Prairie, Minnesota, the company focuses on a large and underserved patient population, including those with diabetic neuropathy and other conditions causing peripheral nerve damage. By leveraging neurostimulation and sensory substitution technology, RxFunction aims to provide a non-invasive solution that enhances quality of life and reduces healthcare costs associated with falls and fractures. The Walkasins device has the potential to become the standard of care for balance disorders in neuropathic patients, offering a novel approach distinct from traditional braces or medications. The company's market opportunity is significant, given the aging population and rising diabetes prevalence globally.

Upcoming Catalysts (preview)

• 2026Expansion of Medicare Coverage and Commercial Reimbursement60% success
• Q4 2026Publication of Pivotal Clinical Data in Peer-Reviewed Journals70% success
• 2027Partnership with Major Diabetes Care or Rehabilitation Distributor50% success